Free Trial

INVO Bioscience Q3 2023 Earnings Report

INVO Bioscience logo
$0.38 +0.00 (+0.05%)
As of 02/21/2025

INVO Bioscience EPS Results

Actual EPS
-$0.70
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

INVO Bioscience Revenue Results

Actual Revenue
$0.98 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

INVO Bioscience Announcement Details

Quarter
Q3 2023
Time
N/A

Conference Call Resources

INVO Bioscience Earnings Headlines

NAYA Biosciences To Raise $9.5 Mln Through Public Offering Of Units
NAYA Biosciences to present insights into mode of action of NY-303
Has Trump finally met his match?
Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance to walk away with gains as high as 235%, 459%, and 700% - all while the stock market got cut in half. Could he be right again?
NAYA Biosciences Inc (INVO)
See More INVO Bioscience Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like INVO Bioscience? Sign up for Earnings360's daily newsletter to receive timely earnings updates on INVO Bioscience and other key companies, straight to your email.

About INVO Bioscience

INVO Bioscience (NASDAQ:INVO), together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

View INVO Bioscience Profile

More Earnings Resources from MarketBeat